Photo from wikipedia
Key Points • Platelet-targeted thrombolysis with SCE5-scuPA achieved favorable outcomes vs tenecteplase-tPA in 2 mouse models of ischemic stroke.• Thrombolytic strategies that harness activated platelets for drug targeting better suit… Click to show full abstract
Key Points • Platelet-targeted thrombolysis with SCE5-scuPA achieved favorable outcomes vs tenecteplase-tPA in 2 mouse models of ischemic stroke.• Thrombolytic strategies that harness activated platelets for drug targeting better suit the platelet-rich nature of stroke-causing thrombi.
Keywords:
platelet targeted;
targeted thrombolysis;
thrombolysis treatment;
platelet;
ischemic stroke
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!